Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR Spectroscopy
- 1 June 2009
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 251 (3) , 653-662
- https://doi.org/10.1148/radiol.2512080553
Abstract
Purpose: To compare changes in the concentration of choline-containing compounds (tCho) and in tumor size at follow-up after neoadjuvant chemotherapy (NAC) between patients who achieved pathologic complete response (pCR) and those who did not (non-pCR). Materials and Methods: This study was approved by the institutional review board and was compliant with HIPAA; each patient gave informed consent. Thirty-five patients (mean age, 48 years ± 11 [standard deviation]; range, 29–75 years) with breast cancer were included. Treatment included doxorubicin and cyclophosphamide followed by a taxane-based regimen. Changes in tCho and tumor size in pCR versus non-pCR groups were compared by using the two-way Mann-Whitney nonparametric test. Receiver operating characteristic (ROC) analysis was performed to differentiate between them and the area under the ROC curve (AUC) was compared. Results: In the pCR group, the tCho level change was greater compared with change in tumor size (P = .003 at first follow-up, P = .01 a...Keywords
This publication has 35 references indexed in Scilit:
- Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapyAnnals of Oncology, 2008
- The Effect of Neoadjuvant Chemotherapy on Histologic Grade, Hormone Receptor Status, and Her2/neu Status in Breast CarcinomaThe Breast Journal, 2008
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27Journal of Clinical Oncology, 2008
- Combined Use of Clinical and Pathologic Staging Variables to Define Outcomes for Breast Cancer Patients Treated With Neoadjuvant TherapyJournal of Clinical Oncology, 2008
- Quantification of Choline-containing Compounds in Malignant Breast Tumors by 1H MR Spectroscopy Using Water as an Internal Reference at 1.5 TMagnetic Resonance Materials in Physics, Biology and Medicine, 2006
- Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapyBreast Cancer Research and Treatment, 2005
- Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of responseCancer, 2004
- MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast CancerAnnals of Surgical Oncology, 2001
- Frequency-selective quantification in the time domainJournal of Magnetic Resonance (1969), 1992
- Water signal elimination in Vivo, using “suppression by mistimed echo and repetitive gradient episodes”Journal of Magnetic Resonance (1969), 1986